| 1 | contacted | 4,184 |
| 2 | checked | 1,848 |
| 3 | handsearched | 571 |
| 4 | hand-searched | 167 |
| 5 | cross-checked | 112 |
| 6 | double-checked | 18 |
| 7 | arbitrated | 12 |
| 8 | browsed | 5 |
| 9 | ginaton | 5 |
| 10 | bio-assayed | 4 |
| 11 | eurocentric | 4 |
| 12 | plead | 4 |
| 13 | re-allocated | 4 |
| 14 | log-rr | 3 |
| 15 | puzzled | 3 |
| 16 | 94-05 | 2 |
| 17 | 94/min | 2 |
| 18 | acounting | 2 |
| 19 | acupuncture/traditional | 2 |
| 20 | cbm-chinese | 2 |
| 21 | echophonocardiography | 2 |
| 22 | fire-toxin | 2 |
| 23 | hand-checked | 2 |
| 24 | hetero-catalytically | 2 |
| 25 | identified.cross-over | 2 |
| 26 | intercell | 2 |
| 27 | intruded | 2 |
| 28 | ireland-based | 2 |
| 29 | m-111 | 2 |
| 30 | non-bioequivalent | 2 |
| 31 | obtained.the | 2 |
| 32 | targetprint/local | 2 |
| 33 | tubings | 2 |
| 34 | uta-ri | 2 |
| 35 | yoshitaka | 2 |
| 36 | 'indications | 1 |
| 37 | 'respect | 1 |
| 38 | +12.64 | 1 |
| 39 | +3.1/minute | 1 |
| 40 | +4.63 | 1 |
| 41 | +9.91 | 1 |
| 42 | -0.76+/-0.3 | 1 |
| 43 | -0.81±0.51 | 1 |
| 44 | -11.38 | 1 |
| 45 | -11.41 | 1 |
| 46 | -12·0° | 1 |
| 47 | -1pt | 1 |
| 48 | -2.10±1.02 | 1 |
| 49 | -2.8±5.6 | 1 |
| 50 | -24.95 | 1 |
| 51 | -29.67 | 1 |
| 52 | -30.0±17.7 | 1 |
| 53 | -5.8±0.5 | 1 |
| 54 | -7/-4 | 1 |
| 55 | -73°c | 1 |
| 56 | -8.1±0.7 | 1 |
| 57 | -9.51+/-0.02 | 1 |
| 58 | -dm350,738 | 1 |
| 59 | -management | 1 |
| 60 | 0,88±1,13mm | 1 |
| 61 | 0.00029-0.00067 | 1 |
| 62 | 0.04-5μg/ml | 1 |
| 63 | 0.04μg/ml | 1 |
| 64 | 0.05microg/ml | 1 |
| 65 | 0.1086 | 1 |
| 66 | 0.14-0.32 | 1 |
| 67 | 0.1681 | 1 |
| 68 | 0.1705 | 1 |
| 69 | 0.184-6.092 | 1 |
| 70 | 0.1meq/l | 1 |
| 71 | 0.2-voxel | 1 |
| 72 | 0.206+/-0.35 | 1 |
| 73 | 0.20mg/kg | 1 |
| 74 | 0.26ng/ml | 1 |
| 75 | 0.3437 | 1 |
| 76 | 0.34:1 | 1 |
| 77 | 0.37±0.14 | 1 |
| 78 | 0.39268 | 1 |
| 79 | 0.41db/cm | 1 |
| 80 | 0.4ng/mg | 1 |
| 81 | 0.5+/-0.7 | 1 |
| 82 | 0.5-250ng/ml | 1 |
| 83 | 0.5-300.0ng/ml | 1 |
| 84 | 0.5-300ng/ml | 1 |
| 85 | 0.50mg/l | 1 |
| 86 | 0.57-0.63 | 1 |
| 87 | 0.6093 | 1 |
| 88 | 0.69/year | 1 |
| 89 | 0.740±0.0195 | 1 |
| 90 | 0.7917 | 1 |
| 91 | 0.79±0.10 | 1 |
| 92 | 0.840-0.940/0.726-0.929 | 1 |
| 93 | 0.8410 | 1 |
| 94 | 0.8551 | 1 |
| 95 | 0.8655 | 1 |
| 96 | 0.9±3.9 | 1 |
| 97 | 01.39 | 1 |
| 98 | 0·071 | 1 |
| 99 | 0·264 | 1 |
| 100 | 1-200ng/ml | 1 |
| 101 | 1-npv | 1 |
| 102 | 1.06±1.78 | 1 |
| 103 | 1.28min | 1 |
| 104 | 1.28±0.85 | 1 |
| 105 | 1.40ng/ml | 1 |
| 106 | 1.5meq/l | 1 |
| 107 | 1.6/year | 1 |
| 108 | 1.6976 | 1 |
| 109 | 1.73-2.18 | 1 |
| 110 | 1.80±0.79coughs/min | 1 |
| 111 | 1.93±0.43 | 1 |
| 112 | 1.95/0.47 | 1 |
| 113 | 1.98-4.92 | 1 |
| 114 | 1/210,656 | 1 |
| 115 | 10,000ppm | 1 |
| 116 | 10.4-18.3mm | 1 |
| 117 | 10.7+/-7.6 | 1 |
| 118 | 10.8+/-6.9 | 1 |
| 119 | 10.9114 | 1 |
| 120 | 100/95.8 | 1 |
| 121 | 102,307 | 1 |
| 122 | 10g/cow/day | 1 |
| 123 | 11.1°c | 1 |
| 124 | 11.4years | 1 |
| 125 | 11.6±0.1 | 1 |
| 126 | 11.6±0.2 | 1 |
| 127 | 12/1997 | 1 |
| 128 | 1200h | 1 |
| 129 | 124±0.5kg | 1 |
| 130 | 127.60 | 1 |
| 131 | 1279.88 | 1 |
| 132 | 128.1/102.1 | 1 |
| 133 | 13,461 | 1 |
| 134 | 13.1±16.9h | 1 |
| 135 | 13.261 | 1 |
| 136 | 13.7+3.1s | 1 |
| 137 | 13.90-18.02 | 1 |
| 138 | 131.4-6131.3 | 1 |
| 139 | 135/85mmhg | 1 |
| 140 | 14.1min | 1 |
| 141 | 14.20-16.00 | 1 |
| 142 | 145±0.8kg | 1 |
| 143 | 15,524.85 | 1 |
| 144 | 15.2±5.9 | 1 |
| 145 | 15.5±1.5 | 1 |
| 146 | 150±32 | 1 |
| 147 | 151/90 | 1 |
| 148 | 16.3:1 | 1 |
| 149 | 161.7s | 1 |
| 150 | 166.6±33.0g | 1 |
| 151 | 17,947 | 1 |
| 152 | 17u/l | 1 |
| 153 | 1891±110kcal | 1 |
| 154 | 189microm | 1 |
| 155 | 19.5° | 1 |
| 156 | 1:14,567 | 1 |
| 157 | 2,450,588 | 1 |
| 158 | 2-chloro-1,3-butadiene | 1 |
| 159 | 2.0+/-1.1 | 1 |
| 160 | 2.03±0.69 | 1 |
| 161 | 2.05°c | 1 |
| 162 | 2.0±5.6 | 1 |
| 163 | 2.11±1.83 | 1 |
| 164 | 2.325 | 1 |
| 165 | 2.5g/kg | 1 |
| 166 | 2.70±1.26 | 1 |
| 167 | 2.75±0.86 | 1 |
| 168 | 2.8/1,000 | 1 |
| 169 | 2.80/wk | 1 |
| 170 | 2.83±12.26ms | 1 |
| 171 | 2.89+0.05 | 1 |
| 172 | 2.9±2 | 1 |
| 173 | 20+/-16 | 1 |
| 174 | 20-30° | 1 |
| 175 | 20-320μg/kg | 1 |
| 176 | 20.9+/-14.6 | 1 |
| 177 | 2007-005553-34 | 1 |
| 178 | 200mg/rat/day | 1 |
| 179 | 204°c | 1 |
| 180 | 20mg/daily | 1 |
| 181 | 20µg/ml | 1 |
| 182 | 22.5±0.5 | 1 |
| 183 | 222±146days | 1 |
| 184 | 23.2±0.8 | 1 |
| 185 | 23.6±13.9 | 1 |
| 186 | 236+/-58 | 1 |
| 187 | 24.084 | 1 |
| 188 | 24.7μm | 1 |
| 189 | 242.44 | 1 |
| 190 | 25.0±1.8 | 1 |
| 191 | 25.2±1.3 | 1 |
| 192 | 25.3±0.8 | 1 |
| 193 | 25.5μm | 1 |
| 194 | 2500mg | 1 |
| 195 | 252.2/155.8 | 1 |
| 196 | 258.1→157.0 | 1 |
| 197 | 26.1±0.5kg/d | 1 |
| 198 | 27.34 | 1 |
| 199 | 27.7° | 1 |
| 200 | 271/248 | 1 |
| 201 | 281.15 | 1 |
| 202 | 29.4+/-7.4 | 1 |
| 203 | 29.4:5.1 | 1 |
| 204 | 3,225 | 1 |
| 205 | 3.0592 | 1 |
| 206 | 3.0months | 1 |
| 207 | 3.1+/-1.9 | 1 |
| 208 | 3.1181 | 1 |
| 209 | 3.17:1 | 1 |
| 210 | 3.2+/-0.5 | 1 |
| 211 | 3.2±2.4 | 1 |
| 212 | 3.38±0.55h | 1 |
| 213 | 3.71-8.98 | 1 |
| 214 | 3.9kg | 1 |
| 215 | 31,956 | 1 |
| 216 | 310/148 | 1 |
| 217 | 317.3/84.1 | 1 |
| 218 | 33.48+/-3.49 | 1 |
| 219 | 34,490 | 1 |
| 220 | 345-fold | 1 |
| 221 | 345→194.5 | 1 |
| 222 | 347.3n | 1 |
| 223 | 35.28°c | 1 |
| 224 | 359.96 | 1 |
| 225 | 365.1±86.6pg/ml | 1 |
| 226 | 37.0+/-10.5 | 1 |
| 227 | 37.6±1.3°c | 1 |
| 228 | 38.7mum | 1 |
| 229 | 38.88±0.18°c | 1 |
| 230 | 39.04±0.24°c | 1 |
| 231 | 39.4+/-11.9 | 1 |
| 232 | 39.407+/-19.535 | 1 |
| 233 | 39.63±0.20°c | 1 |
| 234 | 39.89±0.16°c | 1 |
| 235 | 395°c | 1 |
| 236 | 3999±700pg/ml | 1 |
| 237 | 3bar | 1 |
| 238 | 4,259 | 1 |
| 239 | 4.5μg/ml | 1 |
| 240 | 4.6+/-3.5 | 1 |
| 241 | 4.7-6.2 | 1 |
| 242 | 419.2→337.1 | 1 |
| 243 | 42c | 1 |
| 244 | 444.1 | 1 |
| 245 | 464.0nm | 1 |
| 246 | 48mg | 1 |
| 247 | 48ng/ml | 1 |
| 248 | 49.0°c | 1 |
| 249 | 5.26+/-0.46 | 1 |
| 250 | 5.843 | 1 |
| 251 | 5.95◦ | 1 |
| 252 | 50.3+/-10.2 | 1 |
| 253 | 512.1 | 1 |
| 254 | 53nm | 1 |
| 255 | 6-35-fold | 1 |
| 256 | 6-montly | 1 |
| 257 | 6.5-8.2μm | 1 |
| 258 | 6.5±1.5 | 1 |
| 259 | 61.2/1000 | 1 |
| 260 | 61.3±23.9 | 1 |
| 261 | 616.2±38.5nm | 1 |
| 262 | 65/3/0/0 | 1 |
| 263 | 6612 | 1 |
| 264 | 670.1miu/ml | 1 |
| 265 | 68/73 | 1 |
| 266 | 6u/kg | 1 |
| 267 | 6·9° | 1 |
| 268 | 7.03-11.23 | 1 |
| 269 | 7.1/1 | 1 |
| 270 | 7.3min | 1 |
| 271 | 72,613 | 1 |
| 272 | 72.8μg/ml | 1 |
| 273 | 75.5+/-5.3 | 1 |
| 274 | 75months | 1 |
| 275 | 75°±3° | 1 |
| 276 | 77,480 | 1 |
| 277 | 7840.66 | 1 |
| 278 | 79.64 | 1 |
| 279 | 79±9.2 | 1 |
| 280 | 8,232 | 1 |
| 281 | 8.480 | 1 |
| 282 | 8.60° | 1 |
| 283 | 8.6°c | 1 |
| 284 | 8.6±10 | 1 |
| 285 | 8.74±1.303 | 1 |
| 286 | 80+/-8h | 1 |
| 287 | 815.40 | 1 |
| 288 | 84-116 | 1 |
| 289 | 8687 | 1 |
| 290 | 8806.44 | 1 |
| 291 | 8950.54 | 1 |
| 292 | 8db | 1 |
| 293 | 8°/2° | 1 |
| 294 | 9,112 | 1 |
| 295 | 9.19°c | 1 |
| 296 | 9.2:1 | 1 |
| 297 | 9.31°c | 1 |
| 298 | 9.5+/-8.7 | 1 |
| 299 | 90months | 1 |
| 300 | 93.1-94.0 | 1 |
| 301 | 93.73 | 1 |
| 302 | 93/100 | 1 |
| 303 | 939°c | 1 |
| 304 | 94.3° | 1 |
| 305 | 96.2+/-3.6 | 1 |
| 306 | 96.4/92.3 | 1 |
| 307 | 968.4 | 1 |
| 308 | 97,681 | 1 |
| 309 | ac-evd | 1 |
| 310 | al1576 | 1 |
| 311 | aldb-expressing | 1 |
| 312 | alfamethyldopa | 1 |
| 313 | alk2/alk3 | 1 |
| 314 | allots | 1 |
| 315 | anti-ficolin-3 | 1 |
| 316 | arixta | 1 |
| 317 | auc0-8h=8150ng×min/ml | 1 |
| 318 | auc=0.834 | 1 |
| 319 | auto-oxidize | 1 |
| 320 | b-sites | 1 |
| 321 | becavicumab | 1 |
| 322 | blindside | 1 |
| 323 | bmc/abmd | 1 |
| 324 | broadband-uvb | 1 |
| 325 | brotazolam | 1 |
| 326 | c10.0 | 1 |
| 327 | c8/c10 | 1 |
| 328 | calculated.protein | 1 |
| 329 | came25-2 | 1 |
| 330 | carer-outcomes | 1 |
| 331 | cefalor | 1 |
| 332 | cloaked | 1 |
| 333 | clopidogrel/ticlopidine | 1 |
| 334 | co-lead | 1 |
| 335 | coabuse | 1 |
| 336 | concentric.the | 1 |
| 337 | conducted.one | 1 |
| 338 | conjonctyl® | 1 |
| 339 | copyrighted | 1 |
| 340 | cryo-cuff | 1 |
| 341 | culposcopy | 1 |
| 342 | cup-a | 1 |
| 343 | cyclophosphamide-fec | 1 |
| 344 | d=1.704 | 1 |
| 345 | delta-value | 1 |
| 346 | described- | 1 |
| 347 | diuresing | 1 |
| 348 | dm11,390 | 1 |
| 349 | emulsifiability | 1 |
| 350 | energise | 1 |
| 351 | eud=81gy | 1 |
| 352 | eur11,096,000 | 1 |
| 353 | eur185 | 1 |
| 354 | euro140 | 1 |
| 355 | euro3294 | 1 |
| 356 | euro378 | 1 |
| 357 | euro412 | 1 |
| 358 | euro574 | 1 |
| 359 | euro7,508 | 1 |
| 360 | euro752 | 1 |
| 361 | euro778/vyg | 1 |
| 362 | eyegrounds | 1 |
| 363 | eyestil® | 1 |
| 364 | fap59/fap64 | 1 |
| 365 | galan | 1 |
| 366 | gasterosteiformes | 1 |
| 367 | gc-fpd | 1 |
| 368 | grimaced | 1 |
| 369 | guiaphenesin | 1 |
| 370 | haharaib | 1 |
| 371 | hct-116-p53 | 1 |
| 372 | hospital-settings | 1 |
| 373 | icu2-cup | 1 |
| 374 | identified.no | 1 |
| 375 | insert69 | 1 |
| 376 | ionization-photoelectron | 1 |
| 377 | isrctn57157825 | 1 |
| 378 | jonchkheere-terpstra | 1 |
| 379 | kc-correction | 1 |
| 380 | kotobuki | 1 |
| 381 | l.m.m | 1 |
| 382 | la2o2co3 | 1 |
| 383 | lancl1 | 1 |
| 384 | lipofectaminetm | 1 |
| 385 | long-axes | 1 |
| 386 | m-107 | 1 |
| 387 | m-108 | 1 |
| 388 | m-114 | 1 |
| 389 | m-41 | 1 |
| 390 | m-69 | 1 |
| 391 | m-95 | 1 |
| 392 | magnitude-of-benefit | 1 |
| 393 | malignancy-remain | 1 |
| 394 | maoa/maob | 1 |
| 395 | medivir | 1 |
| 396 | micro-incentives | 1 |
| 397 | n=0.011 | 1 |
| 398 | n=0.012 | 1 |
| 399 | n=5979 | 1 |
| 400 | n=7286 | 1 |
| 401 | nanofluidics | 1 |
| 402 | nct00456508 | 1 |
| 403 | nct01314716 | 1 |
| 404 | nct01429064 | 1 |
| 405 | necesssity | 1 |
| 406 | no-point-applications | 1 |
| 407 | non-disturbing | 1 |
| 408 | non-nephrology | 1 |
| 409 | nonnutritious | 1 |
| 410 | nonsticky | 1 |
| 411 | norneocryptolepines | 1 |
| 412 | nr6a1 | 1 |
| 413 | ny-eso-1115-138 | 1 |
| 414 | ny-eso-185-108 | 1 |
| 415 | odiv1 | 1 |
| 416 | olkin-based | 1 |
| 417 | overmonitoring | 1 |
| 418 | p=0.0338 | 1 |
| 419 | p=0.1011 | 1 |
| 420 | papps-99 | 1 |
| 421 | pca3-incorporating | 1 |
| 422 | pcaggs | 1 |
| 423 | pdc5 | 1 |
| 424 | photoscreen | 1 |
| 425 | piperacillin-tazobactam+vancomycin | 1 |
| 426 | post-2004 | 1 |
| 427 | post-ahv | 1 |
| 428 | post-ndtrs | 1 |
| 429 | post-workshift | 1 |
| 430 | pr3-anca-positivity | 1 |
| 431 | pranayamas | 1 |
| 432 | pre-ndtrs | 1 |
| 433 | presented.no | 1 |
| 434 | preventig | 1 |
| 435 | process.the | 1 |
| 436 | psycholeptics | 1 |
| 437 | r=.63 | 1 |
| 438 | r=.73 | 1 |
| 439 | radioimmunoanalysis | 1 |
| 440 | range=15.7-16.5 | 1 |
| 441 | ratiocmax | 1 |
| 442 | rationalle | 1 |
| 443 | reagent-appropriate | 1 |
| 444 | references.two | 1 |
| 445 | rtx-opp | 1 |
| 446 | rumpling | 1 |
| 447 | sc-7 | 1 |
| 448 | sds/chord | 1 |
| 449 | sdui | 1 |
| 450 | shuster | 1 |
| 451 | shuttered | 1 |
| 452 | siepmann | 1 |
| 453 | skill-sets | 1 |
| 454 | soils/sediments | 1 |
| 455 | soldierly | 1 |
| 456 | spss10 | 1 |
| 457 | stat/transfer | 1 |
| 458 | stragury | 1 |
| 459 | sucs | 1 |
| 460 | technology-certified | 1 |
| 461 | tegafur/leucovorin | 1 |
| 462 | terminal-care | 1 |
| 463 | tested.the | 1 |
| 464 | tetra-primers | 1 |
| 465 | therapeis | 1 |
| 466 | thrgibbs1f90 | 1 |
| 467 | time-to-readiness | 1 |
| 468 | tistr5606 | 1 |
| 469 | trimethoprim-sulphametoxazole | 1 |
| 470 | trp229 | 1 |
| 471 | v1359 | 1 |
| 472 | viwandani | 1 |
| 473 | voluven+hvhf | 1 |
| 474 | x=5 | 1 |
| 475 | £12,471 | 1 |
| 476 | £1509 | 1 |
| 477 | £1596 | 1 |
| 478 | £161.92 | 1 |
| 479 | £17.42 | 1 |
| 480 | £1930 | 1 |
| 481 | £2,600 | 1 |
| 482 | £3161 | 1 |
| 483 | £34.45 | 1 |
| 484 | £375.86 | 1 |
| 485 | £81.87 | 1 |
| 486 | £8348 | 1 |
| 487 | £8414 | 1 |
| 488 | α=0.84 | 1 |
| 489 | δ14.9 | 1 |
| 490 | €1,656 | 1 |
| 491 | €1,960 | 1 |
| 492 | €12,454 | 1 |
| 493 | €14,931 | 1 |
| 494 | €15,363 | 1 |
| 495 | €2,851 | 1 |
| 496 | €29,815 | 1 |
| 497 | €30,297 | 1 |
| 498 | €3548 | 1 |
| 499 | €5,892 | 1 |
| 500 | €5293 | 1 |
| 501 | €54 | 1 |
| 502 | €5617 | 1 |
| 503 | €5676.7 | 1 |
| 504 | €6.31 | 1 |
| 505 | €6324 | 1 |
| 506 | €6757/qaly | 1 |
| 507 | €683 | 1 |
| 508 | €6995 | 1 |
| 509 | €7340 | 1 |
| 510 | €7358 | 1 |
| 511 | €75,201 | 1 |
| 512 | €7910 | 1 |
| 513 | €85.565/€46.602 | 1 |
| 514 | €9.0 | 1 |
| 515 | ≥0.005μg/kg/wk/g/l | 1 |
| 516 | ≥102cm | 1 |
| 517 | ≥30mg/l | 1 |
| 1 | 'indications | 1 |
| 2 | 'respect | 1 |
| 3 | +12.64 | 1 |
| 4 | +3.1/minute | 1 |
| 5 | +4.63 | 1 |
| 6 | +9.91 | 1 |
| 7 | -0.76+/-0.3 | 1 |
| 8 | -0.81±0.51 | 1 |
| 9 | -11.38 | 1 |
| 10 | -11.41 | 1 |
| 11 | -12·0° | 1 |
| 12 | -1pt | 1 |
| 13 | -2.10±1.02 | 1 |
| 14 | -2.8±5.6 | 1 |
| 15 | -24.95 | 1 |
| 16 | -29.67 | 1 |
| 17 | -30.0±17.7 | 1 |
| 18 | -5.8±0.5 | 1 |
| 19 | -7/-4 | 1 |
| 20 | -73°c | 1 |
| 21 | -8.1±0.7 | 1 |
| 22 | -9.51+/-0.02 | 1 |
| 23 | -dm350,738 | 1 |
| 24 | -management | 1 |
| 25 | 0,88±1,13mm | 1 |
| 26 | 0.00029-0.00067 | 1 |
| 27 | 0.04-5μg/ml | 1 |
| 28 | 0.04μg/ml | 1 |
| 29 | 0.05microg/ml | 1 |
| 30 | 0.1086 | 1 |
| 31 | 0.14-0.32 | 1 |
| 32 | 0.1681 | 1 |
| 33 | 0.1705 | 1 |
| 34 | 0.184-6.092 | 1 |
| 35 | 0.1meq/l | 1 |
| 36 | 0.2-voxel | 1 |
| 37 | 0.206+/-0.35 | 1 |
| 38 | 0.20mg/kg | 1 |
| 39 | 0.26ng/ml | 1 |
| 40 | 0.3437 | 1 |
| 41 | 0.34:1 | 1 |
| 42 | 0.37±0.14 | 1 |
| 43 | 0.39268 | 1 |
| 44 | 0.41db/cm | 1 |
| 45 | 0.4ng/mg | 1 |
| 46 | 0.5+/-0.7 | 1 |
| 47 | 0.5-250ng/ml | 1 |
| 48 | 0.5-300.0ng/ml | 1 |
| 49 | 0.5-300ng/ml | 1 |
| 50 | 0.50mg/l | 1 |
| 51 | 0.57-0.63 | 1 |
| 52 | 0.6093 | 1 |
| 53 | 0.69/year | 1 |
| 54 | 0.740±0.0195 | 1 |
| 55 | 0.7917 | 1 |
| 56 | 0.79±0.10 | 1 |
| 57 | 0.840-0.940/0.726-0.929 | 1 |
| 58 | 0.8410 | 1 |
| 59 | 0.8551 | 1 |
| 60 | 0.8655 | 1 |
| 61 | 0.9±3.9 | 1 |
| 62 | 01.39 | 1 |
| 63 | 0·071 | 1 |
| 64 | 0·264 | 1 |
| 65 | 1-200ng/ml | 1 |
| 66 | 1-npv | 1 |
| 67 | 1.06±1.78 | 1 |
| 68 | 1.28min | 1 |
| 69 | 1.28±0.85 | 1 |
| 70 | 1.40ng/ml | 1 |
| 71 | 1.5meq/l | 1 |
| 72 | 1.6/year | 1 |
| 73 | 1.6976 | 1 |
| 74 | 1.73-2.18 | 1 |
| 75 | 1.80±0.79coughs/min | 1 |
| 76 | 1.93±0.43 | 1 |
| 77 | 1.95/0.47 | 1 |
| 78 | 1.98-4.92 | 1 |
| 79 | 1/210,656 | 1 |
| 80 | 10,000ppm | 1 |
| 81 | 10.4-18.3mm | 1 |
| 82 | 10.7+/-7.6 | 1 |
| 83 | 10.8+/-6.9 | 1 |
| 84 | 10.9114 | 1 |
| 85 | 100/95.8 | 1 |
| 86 | 102,307 | 1 |
| 87 | 10g/cow/day | 1 |
| 88 | 11.1°c | 1 |
| 89 | 11.4years | 1 |
| 90 | 11.6±0.1 | 1 |
| 91 | 11.6±0.2 | 1 |
| 92 | 12/1997 | 1 |
| 93 | 1200h | 1 |
| 94 | 124±0.5kg | 1 |
| 95 | 127.60 | 1 |
| 96 | 1279.88 | 1 |
| 97 | 128.1/102.1 | 1 |
| 98 | 13,461 | 1 |
| 99 | 13.1±16.9h | 1 |
| 100 | 13.261 | 1 |
| 101 | 13.7+3.1s | 1 |
| 102 | 13.90-18.02 | 1 |
| 103 | 131.4-6131.3 | 1 |
| 104 | 135/85mmhg | 1 |
| 105 | 14.1min | 1 |
| 106 | 14.20-16.00 | 1 |
| 107 | 145±0.8kg | 1 |
| 108 | 15,524.85 | 1 |
| 109 | 15.2±5.9 | 1 |
| 110 | 15.5±1.5 | 1 |
| 111 | 150±32 | 1 |
| 112 | 151/90 | 1 |
| 113 | 16.3:1 | 1 |
| 114 | 161.7s | 1 |
| 115 | 166.6±33.0g | 1 |
| 116 | 17,947 | 1 |
| 117 | 17u/l | 1 |
| 118 | 1891±110kcal | 1 |
| 119 | 189microm | 1 |
| 120 | 19.5° | 1 |
| 121 | 1:14,567 | 1 |
| 122 | 2,450,588 | 1 |
| 123 | 2-chloro-1,3-butadiene | 1 |
| 124 | 2.0+/-1.1 | 1 |
| 125 | 2.03±0.69 | 1 |
| 126 | 2.05°c | 1 |
| 127 | 2.0±5.6 | 1 |
| 128 | 2.11±1.83 | 1 |
| 129 | 2.325 | 1 |
| 130 | 2.5g/kg | 1 |
| 131 | 2.70±1.26 | 1 |
| 132 | 2.75±0.86 | 1 |
| 133 | 2.8/1,000 | 1 |
| 134 | 2.80/wk | 1 |
| 135 | 2.83±12.26ms | 1 |
| 136 | 2.89+0.05 | 1 |
| 137 | 2.9±2 | 1 |
| 138 | 20+/-16 | 1 |
| 139 | 20-30° | 1 |
| 140 | 20-320μg/kg | 1 |
| 141 | 20.9+/-14.6 | 1 |
| 142 | 2007-005553-34 | 1 |
| 143 | 200mg/rat/day | 1 |
| 144 | 204°c | 1 |
| 145 | 20mg/daily | 1 |
| 146 | 20µg/ml | 1 |
| 147 | 22.5±0.5 | 1 |
| 148 | 222±146days | 1 |
| 149 | 23.2±0.8 | 1 |
| 150 | 23.6±13.9 | 1 |
| 151 | 236+/-58 | 1 |
| 152 | 24.084 | 1 |
| 153 | 24.7μm | 1 |
| 154 | 242.44 | 1 |
| 155 | 25.0±1.8 | 1 |
| 156 | 25.2±1.3 | 1 |
| 157 | 25.3±0.8 | 1 |
| 158 | 25.5μm | 1 |
| 159 | 2500mg | 1 |
| 160 | 252.2/155.8 | 1 |
| 161 | 258.1→157.0 | 1 |
| 162 | 26.1±0.5kg/d | 1 |
| 163 | 27.34 | 1 |
| 164 | 27.7° | 1 |
| 165 | 271/248 | 1 |
| 166 | 281.15 | 1 |
| 167 | 29.4+/-7.4 | 1 |
| 168 | 29.4:5.1 | 1 |
| 169 | 3,225 | 1 |
| 170 | 3.0592 | 1 |
| 171 | 3.0months | 1 |
| 172 | 3.1+/-1.9 | 1 |
| 173 | 3.1181 | 1 |
| 174 | 3.17:1 | 1 |
| 175 | 3.2+/-0.5 | 1 |
| 176 | 3.2±2.4 | 1 |
| 177 | 3.38±0.55h | 1 |
| 178 | 3.71-8.98 | 1 |
| 179 | 3.9kg | 1 |
| 180 | 31,956 | 1 |
| 181 | 310/148 | 1 |
| 182 | 317.3/84.1 | 1 |
| 183 | 33.48+/-3.49 | 1 |
| 184 | 34,490 | 1 |
| 185 | 345-fold | 1 |
| 186 | 345→194.5 | 1 |
| 187 | 347.3n | 1 |
| 188 | 35.28°c | 1 |
| 189 | 359.96 | 1 |
| 190 | 365.1±86.6pg/ml | 1 |
| 191 | 37.0+/-10.5 | 1 |
| 192 | 37.6±1.3°c | 1 |
| 193 | 38.7mum | 1 |
| 194 | 38.88±0.18°c | 1 |
| 195 | 39.04±0.24°c | 1 |
| 196 | 39.4+/-11.9 | 1 |
| 197 | 39.407+/-19.535 | 1 |
| 198 | 39.63±0.20°c | 1 |
| 199 | 39.89±0.16°c | 1 |
| 200 | 395°c | 1 |
| 201 | 3999±700pg/ml | 1 |
| 202 | 3bar | 1 |
| 203 | 4,259 | 1 |
| 204 | 4.5μg/ml | 1 |
| 205 | 4.6+/-3.5 | 1 |
| 206 | 4.7-6.2 | 1 |
| 207 | 419.2→337.1 | 1 |
| 208 | 42c | 1 |
| 209 | 444.1 | 1 |
| 210 | 464.0nm | 1 |
| 211 | 48mg | 1 |
| 212 | 48ng/ml | 1 |
| 213 | 49.0°c | 1 |
| 214 | 5.26+/-0.46 | 1 |
| 215 | 5.843 | 1 |
| 216 | 5.95◦ | 1 |
| 217 | 50.3+/-10.2 | 1 |
| 218 | 512.1 | 1 |
| 219 | 53nm | 1 |
| 220 | 6-35-fold | 1 |
| 221 | 6-montly | 1 |
| 222 | 6.5-8.2μm | 1 |
| 223 | 6.5±1.5 | 1 |
| 224 | 61.2/1000 | 1 |
| 225 | 61.3±23.9 | 1 |
| 226 | 616.2±38.5nm | 1 |
| 227 | 65/3/0/0 | 1 |
| 228 | 6612 | 1 |
| 229 | 670.1miu/ml | 1 |
| 230 | 68/73 | 1 |
| 231 | 6u/kg | 1 |
| 232 | 6·9° | 1 |
| 233 | 7.03-11.23 | 1 |
| 234 | 7.1/1 | 1 |
| 235 | 7.3min | 1 |
| 236 | 72,613 | 1 |
| 237 | 72.8μg/ml | 1 |
| 238 | 75.5+/-5.3 | 1 |
| 239 | 75months | 1 |
| 240 | 75°±3° | 1 |
| 241 | 77,480 | 1 |
| 242 | 7840.66 | 1 |
| 243 | 79.64 | 1 |
| 244 | 79±9.2 | 1 |
| 245 | 8,232 | 1 |
| 246 | 8.480 | 1 |
| 247 | 8.60° | 1 |
| 248 | 8.6°c | 1 |
| 249 | 8.6±10 | 1 |
| 250 | 8.74±1.303 | 1 |
| 251 | 80+/-8h | 1 |
| 252 | 815.40 | 1 |
| 253 | 84-116 | 1 |
| 254 | 8687 | 1 |
| 255 | 8806.44 | 1 |
| 256 | 8950.54 | 1 |
| 257 | 8db | 1 |
| 258 | 8°/2° | 1 |
| 259 | 9,112 | 1 |
| 260 | 9.19°c | 1 |
| 261 | 9.2:1 | 1 |
| 262 | 9.31°c | 1 |
| 263 | 9.5+/-8.7 | 1 |
| 264 | 90months | 1 |
| 265 | 93.1-94.0 | 1 |
| 266 | 93.73 | 1 |
| 267 | 93/100 | 1 |
| 268 | 939°c | 1 |
| 269 | 94-05 | 2 |
| 270 | 94.3° | 1 |
| 271 | 94/min | 2 |
| 272 | 96.2+/-3.6 | 1 |
| 273 | 96.4/92.3 | 1 |
| 274 | 968.4 | 1 |
| 275 | 97,681 | 1 |
| 276 | ac-evd | 1 |
| 277 | acounting | 2 |
| 278 | acupuncture/traditional | 2 |
| 279 | al1576 | 1 |
| 280 | aldb-expressing | 1 |
| 281 | alfamethyldopa | 1 |
| 282 | alk2/alk3 | 1 |
| 283 | allots | 1 |
| 284 | anti-ficolin-3 | 1 |
| 285 | arbitrated | 12 |
| 286 | arixta | 1 |
| 287 | auc0-8h=8150ng×min/ml | 1 |
| 288 | auc=0.834 | 1 |
| 289 | auto-oxidize | 1 |
| 290 | b-sites | 1 |
| 291 | becavicumab | 1 |
| 292 | bio-assayed | 4 |
| 293 | blindside | 1 |
| 294 | bmc/abmd | 1 |
| 295 | broadband-uvb | 1 |
| 296 | brotazolam | 1 |
| 297 | browsed | 5 |
| 298 | c10.0 | 1 |
| 299 | c8/c10 | 1 |
| 300 | calculated.protein | 1 |
| 301 | came25-2 | 1 |
| 302 | carer-outcomes | 1 |
| 303 | cbm-chinese | 2 |
| 304 | cefalor | 1 |
| 305 | checked | 1,848 |
| 306 | cloaked | 1 |
| 307 | clopidogrel/ticlopidine | 1 |
| 308 | co-lead | 1 |
| 309 | coabuse | 1 |
| 310 | concentric.the | 1 |
| 311 | conducted.one | 1 |
| 312 | conjonctyl® | 1 |
| 313 | contacted | 4,184 |
| 314 | copyrighted | 1 |
| 315 | cross-checked | 112 |
| 316 | cryo-cuff | 1 |
| 317 | culposcopy | 1 |
| 318 | cup-a | 1 |
| 319 | cyclophosphamide-fec | 1 |
| 320 | d=1.704 | 1 |
| 321 | delta-value | 1 |
| 322 | described- | 1 |
| 323 | diuresing | 1 |
| 324 | dm11,390 | 1 |
| 325 | double-checked | 18 |
| 326 | echophonocardiography | 2 |
| 327 | emulsifiability | 1 |
| 328 | energise | 1 |
| 329 | eud=81gy | 1 |
| 330 | eur11,096,000 | 1 |
| 331 | eur185 | 1 |
| 332 | euro140 | 1 |
| 333 | euro3294 | 1 |
| 334 | euro378 | 1 |
| 335 | euro412 | 1 |
| 336 | euro574 | 1 |
| 337 | euro7,508 | 1 |
| 338 | euro752 | 1 |
| 339 | euro778/vyg | 1 |
| 340 | eurocentric | 4 |
| 341 | eyegrounds | 1 |
| 342 | eyestil® | 1 |
| 343 | fap59/fap64 | 1 |
| 344 | fire-toxin | 2 |
| 345 | galan | 1 |
| 346 | gasterosteiformes | 1 |
| 347 | gc-fpd | 1 |
| 348 | ginaton | 5 |
| 349 | grimaced | 1 |
| 350 | guiaphenesin | 1 |
| 351 | haharaib | 1 |
| 352 | hand-checked | 2 |
| 353 | hand-searched | 167 |
| 354 | handsearched | 571 |
| 355 | hct-116-p53 | 1 |
| 356 | hetero-catalytically | 2 |
| 357 | hospital-settings | 1 |
| 358 | icu2-cup | 1 |
| 359 | identified.cross-over | 2 |
| 360 | identified.no | 1 |
| 361 | insert69 | 1 |
| 362 | intercell | 2 |
| 363 | intruded | 2 |
| 364 | ionization-photoelectron | 1 |
| 365 | ireland-based | 2 |
| 366 | isrctn57157825 | 1 |
| 367 | jonchkheere-terpstra | 1 |
| 368 | kc-correction | 1 |
| 369 | kotobuki | 1 |
| 370 | l.m.m | 1 |
| 371 | la2o2co3 | 1 |
| 372 | lancl1 | 1 |
| 373 | lipofectaminetm | 1 |
| 374 | log-rr | 3 |
| 375 | long-axes | 1 |
| 376 | m-107 | 1 |
| 377 | m-108 | 1 |
| 378 | m-111 | 2 |
| 379 | m-114 | 1 |
| 380 | m-41 | 1 |
| 381 | m-69 | 1 |
| 382 | m-95 | 1 |
| 383 | magnitude-of-benefit | 1 |
| 384 | malignancy-remain | 1 |
| 385 | maoa/maob | 1 |
| 386 | medivir | 1 |
| 387 | micro-incentives | 1 |
| 388 | n=0.011 | 1 |
| 389 | n=0.012 | 1 |
| 390 | n=5979 | 1 |
| 391 | n=7286 | 1 |
| 392 | nanofluidics | 1 |
| 393 | nct00456508 | 1 |
| 394 | nct01314716 | 1 |
| 395 | nct01429064 | 1 |
| 396 | necesssity | 1 |
| 397 | no-point-applications | 1 |
| 398 | non-bioequivalent | 2 |
| 399 | non-disturbing | 1 |
| 400 | non-nephrology | 1 |
| 401 | nonnutritious | 1 |
| 402 | nonsticky | 1 |
| 403 | norneocryptolepines | 1 |
| 404 | nr6a1 | 1 |
| 405 | ny-eso-1115-138 | 1 |
| 406 | ny-eso-185-108 | 1 |
| 407 | obtained.the | 2 |
| 408 | odiv1 | 1 |
| 409 | olkin-based | 1 |
| 410 | overmonitoring | 1 |
| 411 | p=0.0338 | 1 |
| 412 | p=0.1011 | 1 |
| 413 | papps-99 | 1 |
| 414 | pca3-incorporating | 1 |
| 415 | pcaggs | 1 |
| 416 | pdc5 | 1 |
| 417 | photoscreen | 1 |
| 418 | piperacillin-tazobactam+vancomycin | 1 |
| 419 | plead | 4 |
| 420 | post-2004 | 1 |
| 421 | post-ahv | 1 |
| 422 | post-ndtrs | 1 |
| 423 | post-workshift | 1 |
| 424 | pr3-anca-positivity | 1 |
| 425 | pranayamas | 1 |
| 426 | pre-ndtrs | 1 |
| 427 | presented.no | 1 |
| 428 | preventig | 1 |
| 429 | process.the | 1 |
| 430 | psycholeptics | 1 |
| 431 | puzzled | 3 |
| 432 | r=.63 | 1 |
| 433 | r=.73 | 1 |
| 434 | radioimmunoanalysis | 1 |
| 435 | range=15.7-16.5 | 1 |
| 436 | ratiocmax | 1 |
| 437 | rationalle | 1 |
| 438 | re-allocated | 4 |
| 439 | reagent-appropriate | 1 |
| 440 | references.two | 1 |
| 441 | rtx-opp | 1 |
| 442 | rumpling | 1 |
| 443 | sc-7 | 1 |
| 444 | sds/chord | 1 |
| 445 | sdui | 1 |
| 446 | shuster | 1 |
| 447 | shuttered | 1 |
| 448 | siepmann | 1 |
| 449 | skill-sets | 1 |
| 450 | soils/sediments | 1 |
| 451 | soldierly | 1 |
| 452 | spss10 | 1 |
| 453 | stat/transfer | 1 |
| 454 | stragury | 1 |
| 455 | sucs | 1 |
| 456 | targetprint/local | 2 |
| 457 | technology-certified | 1 |
| 458 | tegafur/leucovorin | 1 |
| 459 | terminal-care | 1 |
| 460 | tested.the | 1 |
| 461 | tetra-primers | 1 |
| 462 | therapeis | 1 |
| 463 | thrgibbs1f90 | 1 |
| 464 | time-to-readiness | 1 |
| 465 | tistr5606 | 1 |
| 466 | trimethoprim-sulphametoxazole | 1 |
| 467 | trp229 | 1 |
| 468 | tubings | 2 |
| 469 | uta-ri | 2 |
| 470 | v1359 | 1 |
| 471 | viwandani | 1 |
| 472 | voluven+hvhf | 1 |
| 473 | x=5 | 1 |
| 474 | yoshitaka | 2 |
| 475 | £12,471 | 1 |
| 476 | £1509 | 1 |
| 477 | £1596 | 1 |
| 478 | £161.92 | 1 |
| 479 | £17.42 | 1 |
| 480 | £1930 | 1 |
| 481 | £2,600 | 1 |
| 482 | £3161 | 1 |
| 483 | £34.45 | 1 |
| 484 | £375.86 | 1 |
| 485 | £81.87 | 1 |
| 486 | £8348 | 1 |
| 487 | £8414 | 1 |
| 488 | α=0.84 | 1 |
| 489 | δ14.9 | 1 |
| 490 | €1,656 | 1 |
| 491 | €1,960 | 1 |
| 492 | €12,454 | 1 |
| 493 | €14,931 | 1 |
| 494 | €15,363 | 1 |
| 495 | €2,851 | 1 |
| 496 | €29,815 | 1 |
| 497 | €30,297 | 1 |
| 498 | €3548 | 1 |
| 499 | €5,892 | 1 |
| 500 | €5293 | 1 |
| 501 | €54 | 1 |
| 502 | €5617 | 1 |
| 503 | €5676.7 | 1 |
| 504 | €6.31 | 1 |
| 505 | €6324 | 1 |
| 506 | €6757/qaly | 1 |
| 507 | €683 | 1 |
| 508 | €6995 | 1 |
| 509 | €7340 | 1 |
| 510 | €7358 | 1 |
| 511 | €75,201 | 1 |
| 512 | €7910 | 1 |
| 513 | €85.565/€46.602 | 1 |
| 514 | €9.0 | 1 |
| 515 | ≥0.005μg/kg/wk/g/l | 1 |
| 516 | ≥102cm | 1 |
| 517 | ≥30mg/l | 1 |
| 1 | described- | 1 |
| 2 | c10.0 | 1 |
| 3 | 93.1-94.0 | 1 |
| 4 | 258.1→157.0 | 1 |
| 5 | €9.0 | 1 |
| 6 | 65/3/0/0 | 1 |
| 7 | 14.20-16.00 | 1 |
| 8 | 2.8/1,000 | 1 |
| 9 | eur11,096,000 | 1 |
| 10 | 61.2/1000 | 1 |
| 11 | 93/100 | 1 |
| 12 | £2,600 | 1 |
| 13 | 0.79±0.10 | 1 |
| 14 | 0.8410 | 1 |
| 15 | €7910 | 1 |
| 16 | c8/c10 | 1 |
| 17 | spss10 | 1 |
| 18 | 8.6±10 | 1 |
| 19 | £1930 | 1 |
| 20 | 815.40 | 1 |
| 21 | euro140 | 1 |
| 22 | €7340 | 1 |
| 23 | 127.60 | 1 |
| 24 | €1,960 | 1 |
| 25 | 77,480 | 1 |
| 26 | 8.480 | 1 |
| 27 | 151/90 | 1 |
| 28 | dm11,390 | 1 |
| 29 | 34,490 | 1 |
| 30 | thrgibbs1f90 | 1 |
| 31 | 11.6±0.1 | 1 |
| 32 | 2.0+/-1.1 | 1 |
| 33 | 128.1/102.1 | 1 |
| 34 | 512.1 | 1 |
| 35 | 444.1 | 1 |
| 36 | 317.3/84.1 | 1 |
| 37 | 29.4:5.1 | 1 |
| 38 | 419.2→337.1 | 1 |
| 39 | 7.1/1 | 1 |
| 40 | €75,201 | 1 |
| 41 | n=0.011 | 1 |
| 42 | p=0.1011 | 1 |
| 43 | m-111 | 2 |
| 44 | €6.31 | 1 |
| 45 | €14,931 | 1 |
| 46 | m-41 | 1 |
| 47 | -11.41 | 1 |
| 48 | -0.81±0.51 | 1 |
| 49 | 0.8551 | 1 |
| 50 | €2,851 | 1 |
| 51 | £3161 | 1 |
| 52 | 13.261 | 1 |
| 53 | 13,461 | 1 |
| 54 | 0·071 | 1 |
| 55 | £12,471 | 1 |
| 56 | 3.1181 | 1 |
| 57 | 97,681 | 1 |
| 58 | 0.1681 | 1 |
| 59 | +9.91 | 1 |
| 60 | 9.2:1 | 1 |
| 61 | 16.3:1 | 1 |
| 62 | 0.34:1 | 1 |
| 63 | 3.17:1 | 1 |
| 64 | nr6a1 | 1 |
| 65 | lancl1 | 1 |
| 66 | odiv1 | 1 |
| 67 | came25-2 | 1 |
| 68 | 50.3+/-10.2 | 1 |
| 69 | 11.6±0.2 | 1 |
| 70 | 4.7-6.2 | 1 |
| 71 | 79±9.2 | 1 |
| 72 | -9.51+/-0.02 | 1 |
| 73 | -2.10±1.02 | 1 |
| 74 | 13.90-18.02 | 1 |
| 75 | €85.565/€46.602 | 1 |
| 76 | n=0.012 | 1 |
| 77 | 9,112 | 1 |
| 78 | euro412 | 1 |
| 79 | 6612 | 1 |
| 80 | 0.14-0.32 | 1 |
| 81 | 8,232 | 1 |
| 82 | 150±32 | 1 |
| 83 | £17.42 | 1 |
| 84 | euro752 | 1 |
| 85 | £161.92 | 1 |
| 86 | 1.98-4.92 | 1 |
| 87 | 0.184-6.092 | 1 |
| 88 | 3.0592 | 1 |
| 89 | €5,892 | 1 |
| 90 | 2.9±2 | 1 |
| 91 | anti-ficolin-3 | 1 |
| 92 | -0.76+/-0.3 | 1 |
| 93 | 131.4-6131.3 | 1 |
| 94 | 25.2±1.3 | 1 |
| 95 | 96.4/92.3 | 1 |
| 96 | 75.5+/-5.3 | 1 |
| 97 | 8.74±1.303 | 1 |
| 98 | 72,613 | 1 |
| 99 | 7.03-11.23 | 1 |
| 100 | 1.93±0.43 | 1 |
| 101 | 5.843 | 1 |
| 102 | hct-116-p53 | 1 |
| 103 | 0.57-0.63 | 1 |
| 104 | +4.63 | 1 |
| 105 | r=.63 | 1 |
| 106 | €15,363 | 1 |
| 107 | 93.73 | 1 |
| 108 | r=.73 | 1 |
| 109 | 68/73 | 1 |
| 110 | 2.11±1.83 | 1 |
| 111 | €683 | 1 |
| 112 | 0.6093 | 1 |
| 113 | €5293 | 1 |
| 114 | alk2/alk3 | 1 |
| 115 | la2o2co3 | 1 |
| 116 | -7/-4 | 1 |
| 117 | 3.2±2.4 | 1 |
| 118 | 29.4+/-7.4 | 1 |
| 119 | 968.4 | 1 |
| 120 | post-2004 | 1 |
| 121 | d=1.704 | 1 |
| 122 | 0.37±0.14 | 1 |
| 123 | m-114 | 1 |
| 124 | 10.9114 | 1 |
| 125 | £8414 | 1 |
| 126 | €6324 | 1 |
| 127 | 2007-005553-34 | 1 |
| 128 | 27.34 | 1 |
| 129 | auc=0.834 | 1 |
| 130 | 242.44 | 1 |
| 131 | 8806.44 | 1 |
| 132 | 8950.54 | 1 |
| 133 | €12,454 | 1 |
| 134 | €54 | 1 |
| 135 | +12.64 | 1 |
| 136 | 79.64 | 1 |
| 137 | nct01429064 | 1 |
| 138 | 0·264 | 1 |
| 139 | fap59/fap64 | 1 |
| 140 | euro574 | 1 |
| 141 | α=0.84 | 1 |
| 142 | 24.084 | 1 |
| 143 | euro3294 | 1 |
| 144 | 3.2+/-0.5 | 1 |
| 145 | 37.0+/-10.5 | 1 |
| 146 | 22.5±0.5 | 1 |
| 147 | -5.8±0.5 | 1 |
| 148 | 15.5±1.5 | 1 |
| 149 | 6.5±1.5 | 1 |
| 150 | 4.6+/-3.5 | 1 |
| 151 | 345→194.5 | 1 |
| 152 | range=15.7-16.5 | 1 |
| 153 | 94-05 | 2 |
| 154 | 2.89+0.05 | 1 |
| 155 | 0.1705 | 1 |
| 156 | 281.15 | 1 |
| 157 | €29,815 | 1 |
| 158 | 3,225 | 1 |
| 159 | 2.325 | 1 |
| 160 | isrctn57157825 | 1 |
| 161 | 0.206+/-0.35 | 1 |
| 162 | 39.407+/-19.535 | 1 |
| 163 | £34.45 | 1 |
| 164 | 0.8655 | 1 |
| 165 | 1.28±0.85 | 1 |
| 166 | 15,524.85 | 1 |
| 167 | eur185 | 1 |
| 168 | m-95 | 1 |
| 169 | -24.95 | 1 |
| 170 | 0.740±0.0195 | 1 |
| 171 | €6995 | 1 |
| 172 | x=5 | 1 |
| 173 | pdc5 | 1 |
| 174 | 96.2+/-3.6 | 1 |
| 175 | 20.9+/-14.6 | 1 |
| 176 | 2.0±5.6 | 1 |
| 177 | -2.8±5.6 | 1 |
| 178 | 10.7+/-7.6 | 1 |
| 179 | tistr5606 | 1 |
| 180 | 20+/-16 | 1 |
| 181 | 84-116 | 1 |
| 182 | nct01314716 | 1 |
| 183 | 2.70±1.26 | 1 |
| 184 | 5.26+/-0.46 | 1 |
| 185 | 1/210,656 | 1 |
| 186 | €1,656 | 1 |
| 187 | 31,956 | 1 |
| 188 | 7840.66 | 1 |
| 189 | al1576 | 1 |
| 190 | 1.6976 | 1 |
| 191 | 2.75±0.86 | 1 |
| 192 | £375.86 | 1 |
| 193 | 0.1086 | 1 |
| 194 | n=7286 | 1 |
| 195 | 359.96 | 1 |
| 196 | £1596 | 1 |
| 197 | sc-7 | 1 |
| 198 | 0.5+/-0.7 | 1 |
| 199 | -8.1±0.7 | 1 |
| 200 | €5676.7 | 1 |
| 201 | -30.0±17.7 | 1 |
| 202 | 9.5+/-8.7 | 1 |
| 203 | m-107 | 1 |
| 204 | 102,307 | 1 |
| 205 | €5617 | 1 |
| 206 | 0.7917 | 1 |
| 207 | 0.3437 | 1 |
| 208 | 1.95/0.47 | 1 |
| 209 | 17,947 | 1 |
| 210 | -29.67 | 1 |
| 211 | 0.00029-0.00067 | 1 |
| 212 | 1:14,567 | 1 |
| 213 | £81.87 | 1 |
| 214 | 8687 | 1 |
| 215 | €30,297 | 1 |
| 216 | 12/1997 | 1 |
| 217 | 23.2±0.8 | 1 |
| 218 | 25.3±0.8 | 1 |
| 219 | 25.0±1.8 | 1 |
| 220 | 252.2/155.8 | 1 |
| 221 | 100/95.8 | 1 |
| 222 | ny-eso-185-108 | 1 |
| 223 | m-108 | 1 |
| 224 | euro7,508 | 1 |
| 225 | nct00456508 | 1 |
| 226 | 1.73-2.18 | 1 |
| 227 | -11.38 | 1 |
| 228 | ny-eso-1115-138 | 1 |
| 229 | p=0.0338 | 1 |
| 230 | -dm350,738 | 1 |
| 231 | 310/148 | 1 |
| 232 | 271/248 | 1 |
| 233 | £8348 | 1 |
| 234 | €3548 | 1 |
| 235 | 236+/-58 | 1 |
| 236 | €7358 | 1 |
| 237 | 0.39268 | 1 |
| 238 | 1.06±1.78 | 1 |
| 239 | euro378 | 1 |
| 240 | 1279.88 | 1 |
| 241 | 2,450,588 | 1 |
| 242 | 3.71-8.98 | 1 |
| 243 | 3.1+/-1.9 | 1 |
| 244 | 39.4+/-11.9 | 1 |
| 245 | 23.6±13.9 | 1 |
| 246 | 61.3±23.9 | 1 |
| 247 | 0.9±3.9 | 1 |
| 248 | δ14.9 | 1 |
| 249 | 15.2±5.9 | 1 |
| 250 | 10.8+/-6.9 | 1 |
| 251 | £1509 | 1 |
| 252 | trp229 | 1 |
| 253 | 0.840-0.940/0.726-0.929 | 1 |
| 254 | 01.39 | 1 |
| 255 | 33.48+/-3.49 | 1 |
| 256 | 4,259 | 1 |
| 257 | v1359 | 1 |
| 258 | m-69 | 1 |
| 259 | 2.03±0.69 | 1 |
| 260 | insert69 | 1 |
| 261 | n=5979 | 1 |
| 262 | papps-99 | 1 |
| 263 | cup-a | 1 |
| 264 | yoshitaka | 2 |
| 265 | alfamethyldopa | 1 |
| 266 | jonchkheere-terpstra | 1 |
| 267 | arixta | 1 |
| 268 | becavicumab | 1 |
| 269 | 8db | 1 |
| 270 | haharaib | 1 |
| 271 | maoa/maob | 1 |
| 272 | broadband-uvb | 1 |
| 273 | 42c | 1 |
| 274 | cyclophosphamide-fec | 1 |
| 275 | eurocentric | 4 |
| 276 | 49.0°c | 1 |
| 277 | 39.63±0.20°c | 1 |
| 278 | 11.1°c | 1 |
| 279 | 9.31°c | 1 |
| 280 | 37.6±1.3°c | 1 |
| 281 | -73°c | 1 |
| 282 | 204°c | 1 |
| 283 | 39.04±0.24°c | 1 |
| 284 | 2.05°c | 1 |
| 285 | 395°c | 1 |
| 286 | 8.6°c | 1 |
| 287 | 39.89±0.16°c | 1 |
| 288 | 38.88±0.18°c | 1 |
| 289 | 35.28°c | 1 |
| 290 | 9.19°c | 1 |
| 291 | 939°c | 1 |
| 292 | 26.1±0.5kg/d | 1 |
| 293 | co-lead | 1 |
| 294 | plead | 4 |
| 295 | grimaced | 1 |
| 296 | intruded | 2 |
| 297 | hand-searched | 167 |
| 298 | handsearched | 571 |
| 299 | technology-certified | 1 |
| 300 | cloaked | 1 |
| 301 | checked | 1,848 |
| 302 | hand-checked | 2 |
| 303 | double-checked | 18 |
| 304 | cross-checked | 112 |
| 305 | puzzled | 3 |
| 306 | shuttered | 1 |
| 307 | ireland-based | 2 |
| 308 | olkin-based | 1 |
| 309 | browsed | 5 |
| 310 | re-allocated | 4 |
| 311 | arbitrated | 12 |
| 312 | contacted | 4,184 |
| 313 | copyrighted | 1 |
| 314 | bio-assayed | 4 |
| 315 | 6-35-fold | 1 |
| 316 | 345-fold | 1 |
| 317 | bmc/abmd | 1 |
| 318 | gc-fpd | 1 |
| 319 | sds/chord | 1 |
| 320 | ac-evd | 1 |
| 321 | blindside | 1 |
| 322 | concentric.the | 1 |
| 323 | obtained.the | 2 |
| 324 | tested.the | 1 |
| 325 | process.the | 1 |
| 326 | rationalle | 1 |
| 327 | trimethoprim-sulphametoxazole | 1 |
| 328 | 2-chloro-1,3-butadiene | 1 |
| 329 | clopidogrel/ticlopidine | 1 |
| 330 | conducted.one | 1 |
| 331 | terminal-care | 1 |
| 332 | cbm-chinese | 2 |
| 333 | energise | 1 |
| 334 | coabuse | 1 |
| 335 | reagent-appropriate | 1 |
| 336 | +3.1/minute | 1 |
| 337 | delta-value | 1 |
| 338 | auto-oxidize | 1 |
| 339 | cryo-cuff | 1 |
| 340 | voluven+hvhf | 1 |
| 341 | 166.6±33.0g | 1 |
| 342 | 135/85mmhg | 1 |
| 343 | preventig | 1 |
| 344 | 2.5g/kg | 1 |
| 345 | 0.20mg/kg | 1 |
| 346 | 20-320μg/kg | 1 |
| 347 | 6u/kg | 1 |
| 348 | 124±0.5kg | 1 |
| 349 | 145±0.8kg | 1 |
| 350 | 3.9kg | 1 |
| 351 | 0.4ng/mg | 1 |
| 352 | 2500mg | 1 |
| 353 | 48mg | 1 |
| 354 | non-disturbing | 1 |
| 355 | rumpling | 1 |
| 356 | overmonitoring | 1 |
| 357 | diuresing | 1 |
| 358 | aldb-expressing | 1 |
| 359 | pca3-incorporating | 1 |
| 360 | acounting | 2 |
| 361 | euro778/vyg | 1 |
| 362 | 1200h | 1 |
| 363 | 3.38±0.55h | 1 |
| 364 | 80+/-8h | 1 |
| 365 | 13.1±16.9h | 1 |
| 366 | kotobuki | 1 |
| 367 | viwandani | 1 |
| 368 | uta-ri | 2 |
| 369 | sdui | 1 |
| 370 | 2.80/wk | 1 |
| 371 | ≥0.005μg/kg/wk/g/l | 1 |
| 372 | ≥30mg/l | 1 |
| 373 | 0.50mg/l | 1 |
| 374 | 0.1meq/l | 1 |
| 375 | 1.5meq/l | 1 |
| 376 | 17u/l | 1 |
| 377 | 1891±110kcal | 1 |
| 378 | targetprint/local | 2 |
| 379 | acupuncture/traditional | 2 |
| 380 | 0.2-voxel | 1 |
| 381 | intercell | 2 |
| 382 | 0.5-300.0ng/ml | 1 |
| 383 | 1-200ng/ml | 1 |
| 384 | 0.5-300ng/ml | 1 |
| 385 | 1.40ng/ml | 1 |
| 386 | 0.5-250ng/ml | 1 |
| 387 | 0.26ng/ml | 1 |
| 388 | 48ng/ml | 1 |
| 389 | 0.05microg/ml | 1 |
| 390 | 3999±700pg/ml | 1 |
| 391 | 365.1±86.6pg/ml | 1 |
| 392 | 20µg/ml | 1 |
| 393 | 0.04μg/ml | 1 |
| 394 | 0.04-5μg/ml | 1 |
| 395 | 4.5μg/ml | 1 |
| 396 | 72.8μg/ml | 1 |
| 397 | auc0-8h=8150ng×min/ml | 1 |
| 398 | 670.1miu/ml | 1 |
| 399 | l.m.m | 1 |
| 400 | brotazolam | 1 |
| 401 | 0.41db/cm | 1 |
| 402 | ≥102cm | 1 |
| 403 | 10.4-18.3mm | 1 |
| 404 | 0,88±1,13mm | 1 |
| 405 | 464.0nm | 1 |
| 406 | 53nm | 1 |
| 407 | 616.2±38.5nm | 1 |
| 408 | 189microm | 1 |
| 409 | 10,000ppm | 1 |
| 410 | lipofectaminetm | 1 |
| 411 | 38.7mum | 1 |
| 412 | 6.5-8.2μm | 1 |
| 413 | 25.5μm | 1 |
| 414 | 24.7μm | 1 |
| 415 | 347.3n | 1 |
| 416 | galan | 1 |
| 417 | photoscreen | 1 |
| 418 | malignancy-remain | 1 |
| 419 | piperacillin-tazobactam+vancomycin | 1 |
| 420 | calculated.protein | 1 |
| 421 | 94/min | 2 |
| 422 | 1.80±0.79coughs/min | 1 |
| 423 | 14.1min | 1 |
| 424 | 7.3min | 1 |
| 425 | 1.28min | 1 |
| 426 | tegafur/leucovorin | 1 |
| 427 | guiaphenesin | 1 |
| 428 | fire-toxin | 2 |
| 429 | siepmann | 1 |
| 430 | kc-correction | 1 |
| 431 | ionization-photoelectron | 1 |
| 432 | ginaton | 5 |
| 433 | identified.no | 1 |
| 434 | presented.no | 1 |
| 435 | references.two | 1 |
| 436 | rtx-opp | 1 |
| 437 | icu2-cup | 1 |
| 438 | 3bar | 1 |
| 439 | 1.6/year | 1 |
| 440 | 0.69/year | 1 |
| 441 | stat/transfer | 1 |
| 442 | shuster | 1 |
| 443 | identified.cross-over | 2 |
| 444 | medivir | 1 |
| 445 | cefalor | 1 |
| 446 | log-rr | 3 |
| 447 | 13.7+3.1s | 1 |
| 448 | 161.7s | 1 |
| 449 | pranayamas | 1 |
| 450 | nanofluidics | 1 |
| 451 | psycholeptics | 1 |
| 452 | sucs | 1 |
| 453 | eyegrounds | 1 |
| 454 | carer-outcomes | 1 |
| 455 | gasterosteiformes | 1 |
| 456 | norneocryptolepines | 1 |
| 457 | b-sites | 1 |
| 458 | micro-incentives | 1 |
| 459 | long-axes | 1 |
| 460 | pcaggs | 1 |
| 461 | tubings | 2 |
| 462 | hospital-settings | 1 |
| 463 | 3.0months | 1 |
| 464 | 90months | 1 |
| 465 | 75months | 1 |
| 466 | therapeis | 1 |
| 467 | radioimmunoanalysis | 1 |
| 468 | 2.83±12.26ms | 1 |
| 469 | 'indications | 1 |
| 470 | no-point-applications | 1 |
| 471 | 11.4years | 1 |
| 472 | tetra-primers | 1 |
| 473 | pre-ndtrs | 1 |
| 474 | post-ndtrs | 1 |
| 475 | time-to-readiness | 1 |
| 476 | skill-sets | 1 |
| 477 | soils/sediments | 1 |
| 478 | allots | 1 |
| 479 | nonnutritious | 1 |
| 480 | 222±146days | 1 |
| 481 | 'respect | 1 |
| 482 | post-workshift | 1 |
| 483 | magnitude-of-benefit | 1 |
| 484 | non-bioequivalent | 2 |
| 485 | -management | 1 |
| 486 | -1pt | 1 |
| 487 | post-ahv | 1 |
| 488 | 1-npv | 1 |
| 489 | ratiocmax | 1 |
| 490 | 200mg/rat/day | 1 |
| 491 | 10g/cow/day | 1 |
| 492 | eud=81gy | 1 |
| 493 | non-nephrology | 1 |
| 494 | echophonocardiography | 2 |
| 495 | nonsticky | 1 |
| 496 | €6757/qaly | 1 |
| 497 | 20mg/daily | 1 |
| 498 | hetero-catalytically | 2 |
| 499 | soldierly | 1 |
| 500 | 6-montly | 1 |
| 501 | culposcopy | 1 |
| 502 | stragury | 1 |
| 503 | emulsifiability | 1 |
| 504 | necesssity | 1 |
| 505 | pr3-anca-positivity | 1 |
| 506 | 5.95◦ | 1 |
| 507 | eyestil® | 1 |
| 508 | conjonctyl® | 1 |
| 509 | 20-30° | 1 |
| 510 | 8.60° | 1 |
| 511 | -12·0° | 1 |
| 512 | 8°/2° | 1 |
| 513 | 94.3° | 1 |
| 514 | 75°±3° | 1 |
| 515 | 19.5° | 1 |
| 516 | 27.7° | 1 |
| 517 | 6·9° | 1 |